Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jan-Dec:11:23247096231166678.
doi: 10.1177/23247096231166678.

Kaposiform Lymphangiomatosis in a Male Adolescent: A Clinical Challenge and the Role of Genetics

Affiliations
Case Reports

Kaposiform Lymphangiomatosis in a Male Adolescent: A Clinical Challenge and the Role of Genetics

Joana Pereira-Nunes et al. J Investig Med High Impact Case Rep. 2023 Jan-Dec.

Abstract

Kaposiform lymphangiomatosis (KLA) is a rare and aggressive generalized lymphatic anomaly (GLA), with distinctive clinical, radiology, morphologic, and genetic features. It does not have a current standard treatment and presents poor overall prognosis. Somatic mutations in the RAS pathway were reported as the likely driver for the majority of patients. We report a case of a 17-year-old male adolescent who was referred to the emergency department due to a severe anemia. Laboratory workup confirmed the anemia and revealed coagulation factor consumption and fibrinolysis. Chest-abdomen-pelvis computed tomography revealed an extensive cervical, mediastinal, abdominal and retroperitoneal "hematoma." During admission, progressive pancytopenia, and disseminated intravascular coagulation were observed, and the hypothesis of a tumor/neoplastic etiology was considered. A thoracoscopy revealed a moderate hemorrhagic pleural effusion and a mediastinal mass resembling a "hemolymphangiomatosis" malformation, which was biopsied. Histology displayed a lymphatic-venous malformation. The patient was presented at the multidisciplinary Vascular Anomalies Center and, due to the complex vascular anomaly diagnosis, oral sirolimus monotherapy was initiated. Four years later, the patient remains clinically stable, with stability of the lesion's dimensions and characteristics. A p.Q61R variant in the NRAS gene [NM_002524.4: c.182A>G, p.(Gln61Arg)], with 5% allelic fraction and 1993x coverage was detected. In conjunction with clinical and pathological findings, it allowed KLA final diagnosis. This case reinforces the importance of a high index of clinical suspicion and highlights the need of referring these cases to referral to Vascular Anomalies Centers.

Keywords: NRAS gene; anemia; disseminated intravascular coagulation; kaposiform hemangioendothelioma; kaposiform lymphangiomatosis; lymphatic malformation; vascular anomaly.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Coronal chest (A) and abdominal (B) T2-weighted MRI images show extensive and infiltrative cervical, mediastinal, abdominal, and retroperitoneal lesion, with bilateral hilar, pleural, mesenteric, and perirectal involvement.
Figure 2.
Figure 2.
Thoracic (A), abdominal (B), and pelvic (C) intranodal lymphangiography reveal delay in contrast progression and deviation to vascular malformation’s ectatic lymphatic channels.
Figure 3.
Figure 3.
The histologic analyses show remarkable presence of dilated lymphatic channels (podoplanin positive). The immunostain for actin displays the irregularity of the vessel wall, due to the irregular proliferation of the muscular layer.

References

    1. Croteau SE, Kozakewich HP, Perez-Atayde AR, et al.. Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly. J Pediatr. 2014;164(2):383-388. - PMC - PubMed
    1. Safi F, Gupta A, Adams D, Anandan V, McCormack FX, Assaly R.Kaposiform lymphangiomatosis, a newly characterized vascular anomaly presenting with hemoptysis in an adult woman. Ann Am Thorac Soc. 2014;11(1):92-95. - PubMed
    1. Barclay SF, Inman KW, Luks VL, McIntyre JB, Al-Ibraheemi A, Church AJ, et al.. A somatic activating NRAS variant associated with kaposiform lymphangiomatosis. Genet Med. 2019;21(7):1517-1524. - PMC - PubMed
    1. Zhou J, Yang K, Chen S, et al.. Sirolimus in the treatment of kaposiform lymphangiomatosis. Orphanet J Rare Dis. 2021; 16(1):260. - PMC - PubMed
    1. Perez-Atayde AR, Debelenko L, Al-Ibraheemi A, et al.. Kaposiform lymphangiomatosis: pathologic aspects in 43 patients. Am J Surg Pathol. 2022;46(7):963-976. - PubMed

Publication types

LinkOut - more resources